What is Tribute Pharmaceuticals Canada Price-to-Operating-Cash-Flow?
As of today (2024-05-03), Tribute Pharmaceuticals Canada's share price is $0.93.
Tribute Pharmaceuticals Canada's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2015 was $-0.02. Hence, Tribute Pharmaceuticals Canada's Price-to-Operating-Cash-Flow Ratio for today is .
The historical rank and industry rank for Tribute Pharmaceuticals Canada's Price-to-Operating-Cash-Flow or its related term are showing as below:
Tribute Pharmaceuticals Canada's Cash Flow from Operations per share for the
three
months ended in Sep. 2015 was $-0.00.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2015 was $-0.02.
Tribute Pharmaceuticals Canada Price-to-Operating-Cash-Flow Historical Data
The historical data trend for Tribute Pharmaceuticals Canada's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tribute Pharmaceuticals Canada Price-to-Operating-Cash-Flow Chart
|
Tribute Pharmaceuticals Canada Annual Data
|
|
Trend |
Dec05 |
Dec06 |
Dec07 |
Dec08 |
Dec09 |
Dec10 |
Dec11 |
Dec12 |
Dec13 |
Dec14 |
| Price-to-Operating-Cash-Flow |
|
Get a 7-Day Free Trial
|
|
|
7.22 |
- |
- |
- |
- |
|
Tribute Pharmaceuticals Canada Quarterly Data
|
|
Dec10 |
Mar11 |
Jun11 |
Sep11 |
Dec11 |
Mar12 |
Jun12 |
Sep12 |
Dec12 |
Mar13 |
Jun13 |
Sep13 |
Dec13 |
Mar14 |
Jun14 |
Sep14 |
Dec14 |
Mar15 |
Jun15 |
Sep15 |
| Price-to-Operating-Cash-Flow |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
- |
- |
- |
- |
- |
Competitive Comparison of Tribute Pharmaceuticals Canada's Price-to-Operating-Cash-Flow
For the Drug Manufacturers - Specialty & Generic subindustry, Tribute Pharmaceuticals Canada's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tribute Pharmaceuticals Canada's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Tribute Pharmaceuticals Canada's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Tribute Pharmaceuticals Canada's Price-to-Operating-Cash-Flow falls into.
Tribute Pharmaceuticals Canada Price-to-Operating-Cash-Flow Calculation
Tribute Pharmaceuticals Canada's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 0.93 | / | -0.016 |
| = | |
Tribute Pharmaceuticals Canada's Share Price of today is $0.93.
Tribute Pharmaceuticals Canada's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2015 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.02.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
Tribute Pharmaceuticals Canada (Tribute Pharmaceuticals Canada) Business Description
Traded in Other Exchanges
N/A
Address
Tribute Pharmaceuticals Canada Inc was incorporated under the Business Corporations Act (Ontario) on November 14, 1994. The Company is a specialty pharmaceutical company. It conducts acquisition, licensing, development and promotion of healthcare products in Canada. It sells Uracyst and NeoVisc internationally through a number of strategic partnerships. The Company's portfolio of assets includes nine product lines, eight of which are on the market in Canada, including: NeoVisc, NeoVisc Single Dose, Uracyst, BladderChek, Bezalip SR, Soriatane, Cambia, Daraprim, Collatamp G, and MycoVa. The Company markets its products in Canada through its own sales force and currently has licensing agreements for the distribution of select products in over 20 countries, and continues to expand this footprint. It faces product competition from companies marketing competing pharmaceutical products and medical devices in Canada. The Company's operations are or may be subject to various federal, provincial, state and local laws, regulations and recommendations relating to the marketing of products and relationships with treating physicians, data protection, safe working conditions, laboratory and manufacturing practices, the export of products to certain countries and the purchase, storage, movement, use and disposal of hazardous or potentially hazardous substances.
Executives
Tribute Pharmaceuticals Canada (Tribute Pharmaceuticals Canada) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TBUFF has been successfully added to your